ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
Hany Akeel Al-hussaniy1 , Raghid R. Altalebi2, Ali H. Albu-Rghaif3 and Abdul-Ghaffar A. Abdul-Amir4
1Department of Clinical Pharmacy, Al-Karama Hospital, Baghdad, Iraq.
2College of Family Physicians of Canada, College of Physicians and Surgeons of Alberta, Canada.
3Department of Pharmacy, Ashur University Collage, Baghdad, Iraq.
4Department of Pharmacology, College of Pharmacy, University of Baghdad, Iraq.
J Pure Appl Microbiol. 2022;16(1):201-206 | Article Number: 7368
https://doi.org/10.22207/JPAM.16.1.10 | © The Author(s). 2022
Received: 12/10/2021 | Accepted: 29/11/2021 | Published online: 07/01/2022
Issue online: March 2022
Abstract

Diseases of the respiratory system are a common cause of antibiotic prescription in Iraq and worldwide. Technology has been recently used for its diagnosis, such as the Film Array Respiratory Panel. This study aims to identify the correlation between the diagnosis and treatment of respiratory tract infections with the result of polymerase chain reaction (PCR) for respiratory viruses. A descriptive, cross-sectional, retrospective study included 134 patients treated at Alkharama Hospital and the Private Hospital in Baghdad, Iraq, in the period from January 2020 to March 2020 For all cases, the results of the panel and the treatment received by the patients were analysed. 58% received antibiotic treatment upon admission, 13% combined treatment (antibiotic + antiviral), 27% received symptomatic treatment, and 2% were treated with the first-instance antiviral. After the result, 38% continued with antibiotics, 30% with antibiotics and antivirals, 13.8% with antivirals and 18.2% with symptomatic treatment. Despite the worldwide alarm over antimicrobial resistance, patients continue to be treated with antibiotics due to a situation that is influenced by several factors.

Keywords

Respiratory viral infections, PR FilmArray, antibiotics, antimicrobial resistance

Article Metrics

Article View: 69

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.